On Monday, Raymond James updated its outlook on Procter & Gamble (NYSE:PG) shares, raising the price target to $190 from $187 while sustaining an Outperform rating on the stock. The firm's analyst noted that Procter & Gamble's first-quarter organic sales growth was consistent with the previous quarter, showing a 2% year-over-year increase, which aligned with market expectations despite concerns of a lower performance.
Procter & Gamble reported a slight earnings per share (EPS) beat, with $1.93 compared to the Raymond James estimate of $1.91 and the consensus of $1.90. The results were buoyed by factors below the operating line, and the company reiterated its full-year sales and EPS outlook.
The analysis highlighted that Procter & Gamble's performance has remained stable since the fourth quarter, with growth in the U.S. and Western Europe balancing out softer markets like China and the Middle East.
North America and Western Europe experienced organic sales growth of 4% and 3% year-over-year, respectively. However, China saw a significant decline, with sales dropping by 15%. Despite these regional disparities, Raymond James believes Procter & Gamble is well-positioned to navigate a potential economic slowdown, citing the company's ability to meet full-year targets amidst cautious Street expectations.
The revised stock price target of $190 reflects a constant target price-to-earnings (P/E) ratio of 26 based on a slightly increased earnings per share estimate for the calendar year 2025. The firm maintains its positive stance on Procter & Gamble's shares, noting that they are trading approximately one standard deviation below the market and peer average relative to Colgate-Palmolive (NYSE:CL).
In other recent news, Procter & Gamble reported minor earnings per share (EPS) beat in the first quarter, with figures at $1.93, surpassing the anticipated $1.91 and the consensus of $1.90. The company also reported a 2% growth in organic sales, with North America showing a 4% increase. Despite a strong overall performance, Procter & Gamble experienced a 15% decline in sales in China.
Raymond James maintained an Outperform rating on Procter & Gamble and increased the price target to $190 from $187. The firm noted that Procter & Gamble's performance has not significantly changed and that the company is in a stronger position than before to handle a potential economic downturn.
The company reiterated its full-year sales and EPS outlook, and plans to return $16 billion to shareholders through dividends and stock repurchases. These are all recent developments for Procter & Gamble, which continues to show resilience in its business model, meeting full-year targets despite increased softness in China and the Middle East.
InvestingPro Insights
Procter & Gamble's strong market position and financial stability are further underscored by recent data from InvestingPro. The company's market capitalization stands at an impressive $403.37 billion, reflecting its status as a prominent player in the Household Products industry. This aligns with Raymond James' positive outlook on the stock.
InvestingPro Tips highlight P&G's commitment to shareholder value, noting that the company has raised its dividend for 41 consecutive years and has maintained dividend payments for 54 consecutive years. This consistent dividend growth, coupled with a current dividend yield of 2.35%, supports the analyst's view of P&G as a reliable investment during potential economic slowdowns.
The company's financial health is evident in its ability to cover interest payments with its cash flows, operating with a moderate level of debt. This financial prudence positions P&G well to navigate market uncertainties, as emphasized in the Raymond James analysis.
It is worth noting that InvestingPro offers 11 additional tips for Procter & Gamble, providing investors with a more comprehensive analysis of the company's financial position and market performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.